Monogram Biosciences is a pioneering company under LabCorp, specializing in the development and commercialization of innovative products to elevate the treatment of infectious diseases, cancer, and other severe illnesses. Their molecular diagnostics and testing services empower healthcare providers to tailor treatment regimens for individual patients, leading to enhanced outcomes and reduced costs. Their focus lies in aligning the molecular elements of a patient's disease with the most effective drugs, ultimately improving therapeutic outcomes.
Moreover, Monogram Biosciences collaborates with pharmaceutical companies to streamline the development of antiviral therapeutics, vaccines, and targeted cancer therapeutics. By providing advanced patient selection and monitoring capabilities, they contribute to a more efficient development process. They have also developed HIV assays, simplifying the management of antiretroviral therapy, and oncology products that expedite the advancement of targeted cancer therapeutics.
Established in 1995, the company operates within the Biotechnology and Health Care industries, with headquarters in the United States. As of now, there is no available information regarding their last investment or the associated investors.
Taxonomy:
molecular diagnostics, infectious diseases, cancer treatment, pharmaceuticals, antiviral therapeutics, vaccine development, oncology products, HIV testing, patient selection, companion diagnostics, personalized medicine, virology assays, healthcare optimization
South San Francisco, United States
